Date published: 2025-11-19

00800 4573 8000

SCBT Portrait Logo
Seach Input

C1q Activadores

C1q activators constitute a diverse array of chemical entities that are characterized by their ability to enhance the functional activity of the C1q protein, a key component of the classical complement pathway. C1q is primarily recognized for its role in the immune system where it binds to the Fc region of antibodies that are attached to pathogens, triggering a series of immune responses that include the opsonization of pathogens and the initiation of a complement cascade resulting in the formation of a membrane attack complex. Activators of C1q can operate through various mechanisms, with some directly binding to the C1q molecule itself, thereby stabilizing its conformation and enhancing its ability to initiate the complement cascade. Others may work by upregulating the cellular pathways that lead to the expression and stabilization of C1q or its receptor interactions, which are essential for its proper functioning in the immune response. These chemicals, while diverse in structure, share the common feature of promoting the activity of C1q without necessarily increasing its expression.

The biochemical activation mechanisms of C1q activators can be quite intricate. Some activators may influence the configuration of C1q, facilitating its interaction with the C1r2s2 complex, which is a crucial step in the activation of the classical pathway. Other compounds may interact with various regulators of complement activation, such as C1 inhibitor (C1-INH), to sustain a favorable balance that promotes C1q function. By influencing the proteases that cleave and activate downstream components of the complement system, such as C4 and C2, these activators indirectly bolster the function of C1q. Although they do not directly modify the protein structure of C1q, their actions on related molecules and signaling pathways result in a net increase in the functional potential of C1q, thus enhancing its role in the immune system's defense mechanisms. Collectively, these activators work in concert to ensure that C1q can effectively fulfill its role in the recognition and clearance of pathogens, as well as in the removal of apoptotic cells, thereby maintaining homeostasis within the immune system.

VER TAMBIÉN ....

Nombre del productoNÚMERO DE CAS #Número de catálogoCantidadPrecioMENCIONESClasificación

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Los inhibidores de la histona desacetilasa pueden modificar la regulación epigenética de la expresión de C1q, lo que podría provocar cambios en su actividad.

MCC950 sodium salt

256373-96-3sc-505904
sc-505904A
sc-505904B
sc-505904C
5 mg
10 mg
50 mg
100 mg
$112.00
$194.00
$871.00
$1538.00
3
(0)

Compuestos como el MCC950 pueden inhibir el inflamasoma NLRP3, que puede tener efectos descendentes en la activación del complemento, incluido el C1q.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

Los compuestos como BAY 11-7082 que inhiben NF-kB podrían afectar a la transcripción de los genes del sistema del complemento, incluido C1q.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$118.00
$320.00
$622.00
$928.00
$1234.00
38
(1)

Los agonistas PPARγ podrían modular la función de los macrófagos, afectando posiblemente a la actividad de C1q de forma indirecta.

FTY720

162359-56-0sc-202161
sc-202161A
sc-202161B
1 mg
5 mg
25 mg
$32.00
$75.00
$118.00
14
(1)

Los moduladores del receptor de esfingosina-1-fosfato podrían influir en la salida y la función de los linfocitos, con posibles efectos secundarios en la actividad de C1q.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

El SB431542 y otros inhibidores de la vía del TGF-β podrían influir en la expresión de los componentes del complemento, incluido el C1q.

BMS-345541

445430-58-0sc-221741
1 mg
$306.00
1
(1)

Los compuestos que inhiben IKK podrían afectar a la señalización de NF-kB y, por tanto, influir en la expresión de C1q.